Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Ayache, Saleh ^a   Panelli, Monica C ^a   Byrne, Karen M ^a   Slezak, Stefanie ^a   Leitman, Susan F ^a   Marincola, Francesco M ^a   Stroncek, David F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT TREATMENT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PLASMA; PROTEOMICS; SERUM;

EID: 33750040237     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-40     Document Type: Article

References (19)

1. Wong EC, Maher VE, Hines K, Lee J, Carter CS, Goletz T, Kopp W, Mackall CL, Berzofsky J, Read EJ: Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy. Cytotherapy 2001, 3:19-29.
2. Pullarkat V, Lau R, Lee SM, Bender JG, Weber JS: Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells. J Immunol Methods 2002, 267:173-183.
3. Tuyaerts S, Noppe SM, Corthals J, Breckpot K, Heirman C, De Greef C, Van RI, Thielemans K: Generation of large numbers of dendritic cells in a closed system using Cell Factories. J Immunol Methods 2002, 264:135-151.
4. Reichardt VL, Milazzo C, Brugger W, Einsele H, Kanz L, Brossart P: Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells. Haematologica 2003, 88:1139-1149.
5. Rosenberg SA: The emergence of modern cancer immunotherapy. Ann Surg Oncol 2005, 12:344-346.
6. Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE: Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 2004, 200:1623-1633.
7. Peggs KS, Mackinnon S: Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy. Hum Immunol 2004, 65:550-557.
8. Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, Loffler J, Grigoleit U, Moris A, Rammensee HG, Kanz L, Kleihauer A, Frank F, Jahn G, Hebart H: Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002, 99:3916-3922.
9. Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, Bearman SI, Nieto Y, Freed B, Madinger N, Hogan CJ, Slat-Vasquez V, Russell P, Blunk B, Schissel D, Hild E, Malcolm J, Ward W, McNiece IK: Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8:368-376.
10. McNiece I, Jones R, Bearman SI, Cagnoni P, Nieto Y, Franklin W, Ryder J, Steele A. Stoltz J, Russell P, McDermitt J, Hogan C, Murphy J, Shpall EJ: Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000, 96:3001-3007.
11. Johnson RT, Gibbs CJJ: Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998, 339:1994-2004.
12. Panelli MC, White R, Foster M, Martin B, Wang E, Smith K, Marincola FM: Forecasting the cytokine storm following systemic interleukin (IL)-2 administration. J Transl Med 2004, 2:17.
13. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
14. Stroncek D, Slezak S, Khuu H, Basil C, Tisdale J, Leitman SF, Marincola FM, Panelli MC: Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor. Exp Hematol 2005. 33:1109-1117,
15. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de WL: Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994, 5:565-574.
16. Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S: Platelets synthesize large amounts of active plasminogen activator inhibitor I. Blood 2004, 104:3943-3948.
17. Watanabe K., Jose PJ, Rankin SM: Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. J Immunol 2002, 168: 168-1918.
18. Bruserud O, Glenjen N, Ryningen A, Ulvestad E: In vitro culture of human acute lymphalastic leukemia (ALL) cells in serumfree medla; a comparison of native ALL lasts, ALL cell lines and virus-transformed B cell lines. Leuk Res 2003, 27:455-464.
19. Bruserud O, Gjertsen BT, von Volkman HL: In vitro culture of human acute myelogenous leukemia (AML) cells in serumfree media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res 2000, 9:923-932.